TELCYTA™ (Canfosfamide HCl) is a first in class investigational cancer cell-activated chemotherapeutic. It was designed to exploit the overexpression of glutathione S-transferase P1-1 (GST P1-1), an enzyme overexpressed in many human cancer cells.

Product: Telcyta™
Marketer: Telik, Inc.
Client: deClarity

View more animations created for deClarity HERE

home | gallery | contact